Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy-Reference-Cited by-同舟云学术

Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy

Published:2012-07-16 Issue:9 Volume:103 Page:1688-1694
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kuwatsuka Yachiyo,Kohno Akio¹,Terakura Seitaro²,Saito Shigeki,Shimada Kazuyuki,Yasuda Takahiko,Inamoto Yoshihiro,Miyamura Koichi³,Sawa Masashi⁴,Murata Makoto²,Karasuno Takahiro⁵,Taniguchi Shuichi⁶,Nagafuji Koji⁷,Atsuta Yoshiko⁸,Suzuki Ritsuro⁸,Fukumoto Mariko⁹,Naoe Tomoki²,Morishita Yoshihisa¹,

Affiliation:

1. Department of Hematology and Oncology; JA Aichi Konan Kosei Hospital; Konan; Japan

2. Department of Hematology and Oncology; Nagoya University Graduate School of Medicine; Nagoya; Japan

3. Department of Hematology; Japanese Red Cross Nagoya First Hospital; Nagoya; Japan

4. Department of Hematology and Oncology; Anjo Kosei Hospital; Anjo; Japan

5. Department of Hematology and Oncology; Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka; Japan

6. Department of Hematology; Toranomon Hospital; Tokyo; Japan

7. Department of Medicine and Biosystemic Science; Kyushu University Graduate School of Medical Sciences; Fukuoka; Japan

8. Department of Hematopoietic Stem Cell Transplantation Data Management; Nagoya University School of Medicine; Nagoya; Japan

9. Division of Toxicology, Center for Clinical Pharmacy and Clinical Sciences, School of Pharmaceutical Sciences; Kitasato University; Tokyo; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2012.02342.x/fullpdf

Reference31 articles.

1. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen;Tutschka;Blood,1987

2. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies;Socie;Blood,2001

3. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation;Slattery;Blood,1997

4. Association of busulfan area under the curve with veno-occlusive disease following BMT;Dix;Bone Marrow Transplant,1996

5. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study;Vassal;Cancer Res,1990

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of a combination oral spray (Mucosamin®) for the prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: a double blind randomized clinical trial;Supportive Care in Cancer;2022-06-23

2. An analysis of oral microbial flora by T-RFLP in patients undergoing hematopoietic stem cell transplantation;International Journal of Hematology;2020-08-08

3. Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning;International Journal of Hematology;2019-09-25

4. Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation;European Journal of Haematology;2019-08-12

5. Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients;Cancer Chemotherapy and Pharmacology;2018-03-06